Digital Content 
NEWS #PharmaBuzz
30 Apr 2024
// Annalee Armstrong FIERCE BIOTECH
https://www.fiercebiotech.com/ai-and-machine-learning/newrons-schizophrenia-add-improves-symptoms-charging-case-phase-3-test
https://www.fda.gov/drugs/drug-safety-and-availability/fda-temporarily-exercising-enforcement-discretion-respect-certain-clozapine-rems-program#:~:text=On%20July%2029%2C%202021%2C%20FDA,able%20to%20prescribe%2Fdispense%20clozapine
13 Dec 2021
// PHARMACIST
https://www.pharmacist.com/Pharmacy-News/fda-puts-clozapine-rems-requirements-on-temporary-hold
19 Nov 2021
// FDA
https://www.fda.gov/drugs/drug-safety-and-availability/fda-temporarily-suspending-certain-clozapine-rems-program-requirements-ensure-continuity-care
29 Jul 2021
// FDA
https://www.fda.gov/drugs/drug-safety-and-availability/clozapine-risk-evaluation-and-mitigation-strategy-rems-requirements-will-change-november-15-2021
29 Jul 2021
// FDA
https://www.fda.gov/drugs/drug-safety-and-availability/clozapine-risk-evaluation-and-mitigation-strategy-rems-requirements-will-change-november-15-2021
Share 